(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three biggest winners today are SmileDirectClub, First Majestic Silver, and The AES.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | SmileDirectClub (SDC) | 0.37 | 5.6% | 2023-05-26 07:29:52 |
| 2 | First Majestic Silver (AG) | 5.89 | 2.26% | 2023-05-26 04:37:33 |
| 3 | The AES (AES) | 20.39 | 2.21% | 2023-05-26 04:37:31 |
| 4 | FuboTV (FUBO) | 1.62 | 1.89% | 2023-05-26 04:47:05 |
| 5 | Royalty Pharma (RPRX) | 32.73 | 1.52% | 2023-05-26 07:26:51 |
| 6 | Redfin (RDFN) | 9.69 | 1.47% | 2023-05-26 07:15:02 |
| 7 | Canopy Growth (CGC) | 0.89 | 1.34% | 2023-05-26 07:21:49 |
| 8 | Beyond Meat (BYND) | 11.00 | 1.29% | 2023-05-26 07:28:24 |
| 9 | Nio (NIO) | 7.61 | 0.93% | 2023-05-26 04:42:55 |
| 10 | Pacific Biosciences of California (PACB) | 12.07 | 0.84% | 2023-05-26 07:26:28 |
The three biggest losers today are Tilray, Canaan, and Nautilus.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Tilray (TLRY) | 1.84 | -22.03% | 2023-05-26 07:30:18 |
| 2 | Canaan (CAN) | 2.40 | -6.95% | 2023-05-26 07:28:26 |
| 3 | Nautilus (NLS) | 1.21 | -3.2% | 2023-05-26 04:43:02 |
| 4 | Fox Corporation (FOX) | 28.31 | -2.11% | 2023-05-26 07:09:46 |
| 5 | Vodafone (VOD) | 9.72 | -1.82% | 2023-05-26 07:27:37 |
| 6 | Virgin Galactic (SPCE) | 3.99 | -1.48% | 2023-05-26 04:46:53 |
| 7 | Lloyds Banking Group (LYG) | 2.22 | -0.89% | 2023-05-26 04:42:20 |
| 8 | Quidel (QDEL) | 84.20 | -0.61% | 2023-05-26 07:11:52 |
| 9 | ING Group (ING) | 12.75 | -0.55% | 2023-05-26 04:41:34 |
| 10 | Catalyst Pharmaceuticals (CPRX) | 11.53 | -0.52% | 2023-05-26 07:23:35 |
Premarket Winners today
1. SmileDirectClub (SDC) – Premarket: 5.6%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub sliding 2.47% to $0.35 on Friday while NASDAQ rose 1.71% to $12,698.09.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.
More news about SmileDirectClub.
2. First Majestic Silver (AG) – Premarket: 2.26%
First Majestic Silver Corp. engages in the acquisition, exploration, development, and production of mineral properties with a focus on silver and gold production in North America. Its projects include the San Dimas mine that consists of 119 individual concessions covering an area of 71,839 hectares located in Durango and Sinaloa States, México; the Santa Elena comprising 32 individual concessions that covers an area of 102,172 hectares located in Sonora State, México; and the La Encantada consists of 22 exploitation concessions covering an area of 4,076 hectares located in Coahuila State, México. The company was formerly known as First Majestic Resource Corp. and changed its name to First Majestic Silver Corp. in November 2006. First Majestic Silver Corp. was incorporated in 1979 and is headquartered in Vancouver, Canada.
NYSE ended the session with First Majestic Silver dropping 3.11% to $5.76 on Friday while NYSE dropped 0.31% to $14,975.97.
Earnings Per Share
As for profitability, First Majestic Silver has a trailing twelve months EPS of $-0.82.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.05%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, First Majestic Silver’s stock is considered to be overbought (>=80).
Earnings Before Interest, Taxes, Depreciation, and Amortization
First Majestic Silver’s EBITDA is 3.09.
Volume
Today’s last reported volume for First Majestic Silver is 3539380 which is 49.26% below its average volume of 6976270.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 300% and 144.4%, respectively.
More news about First Majestic Silver.
3. The AES (AES) – Premarket: 2.21%
The AES Corporation operates as a diversified power generation and utility company. It owns and/or operates power plants to generate and sell power to customers, such as utilities, industrial users, and other intermediaries. The company also owns and/or operates utilities to generate or purchase, distribute, transmit, and sell electricity to end-user customers in the residential, commercial, industrial, and governmental sectors; and generates and sells electricity on the wholesale market. It uses a range of fuels and technologies to generate electricity, including coal, gas, hydro, wind, solar, and biomass; and renewables, such as energy storage and landfill gas. The company owns and/or operates a generation portfolio of approximately 32,326 megawatts. It has operations in the United States, Puerto Rico, El Salvador, Chile, Colombia, Argentina, Brazil, Mexico, Central America, the Caribbean, Europe, and Asia. The company was formerly known as Applied Energy Services, Inc. and changed its name to The AES Corporation in April 2000. The AES Corporation was incorporated in 1981 and is headquartered in Arlington, Virginia.
NYSE ended the session with The AES falling 1.51% to $19.95 on Friday, after three consecutive sessions in a row of losses. NYSE slid 0.31% to $14,975.97, after five consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, The AES has a trailing twelve months EPS of $-0.77.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.4%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.6%, now sitting on 13B for the twelve trailing months.
Moving Average
The AES’s value is way under its 50-day moving average of $23.16 and way below its 200-day moving average of $25.49.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 27, 2023, the estimated forward annual dividend rate is 0.66 and the estimated forward annual dividend yield is 3.19%.
More news about The AES.
4. FuboTV (FUBO) – Premarket: 1.89%
fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.
NYSE ended the session with FuboTV sliding 5.92% to $1.59 on Friday while NYSE fell 0.31% to $14,975.97.
Earnings Per Share
As for profitability, FuboTV has a trailing twelve months EPS of $-1.71.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 50.8% and 56.1%, respectively.
Volatility
FuboTV’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.80%, a positive 3.28%, and a positive 7.00%.
FuboTV’s highest amplitude of average volatility was 5.17% (last week), 8.98% (last month), and 7.00% (last quarter).
More news about FuboTV.
5. Royalty Pharma (RPRX) – Premarket: 1.52%
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
NASDAQ ended the session with Royalty Pharma rising 0.06% to $32.24 on Friday, following the last session’s upward trend. NASDAQ rose 1.71% to $12,698.09, following the last session’s upward trend on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, Royalty Pharma has a trailing twelve months EPS of $0.73.
PE Ratio
Royalty Pharma has a trailing twelve months price to earnings ratio of 44.16. Meaning, the purchaser of the share is investing $44.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.12%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Royalty Pharma’s EBITDA is 8.51.
More news about Royalty Pharma.
6. Redfin (RDFN) – Premarket: 1.47%
Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; and originates and sells mortgages. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Redfin dropping 2.7% to $9.55 on Friday while NASDAQ rose 1.71% to $12,698.09.
Earnings Per Share
As for profitability, Redfin has a trailing twelve months EPS of $-2.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -173.25%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Redfin’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for Redfin is 1382400 which is 55.75% below its average volume of 3124610.
More news about Redfin.
7. Canopy Growth (CGC) – Premarket: 1.34%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth falling 16.23% to $0.88 on Friday, after five consecutive sessions in a row of losses. NASDAQ jumped 1.71% to $12,698.09, following the last session’s upward trend on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-5.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112%.
Volume
Today’s last reported volume for Canopy Growth is 26350800 which is 320.24% above its average volume of 6270360.
More news about Canopy Growth.
8. Beyond Meat (BYND) – Premarket: 1.29%
Beyond Meat, Inc. develops, manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club, convenience, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools. The company was formerly known as Savage River, Inc. and changed its name to Beyond Meat, Inc. in September 2018. Beyond Meat, Inc. was founded in 2009 and is headquartered in El Segundo, California.
NASDAQ ended the session with Beyond Meat sliding 5.03% to $10.86 on Friday, following the last session’s downward trend. NASDAQ rose 1.71% to $12,698.09, following the last session’s upward trend on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, Beyond Meat has a trailing twelve months EPS of $-4.84.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 43.1% and 50.6%, respectively.
Volatility
Beyond Meat’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.33%, a negative 0.95%, and a positive 3.12%.
Beyond Meat’s highest amplitude of average volatility was 3.00% (last week), 4.14% (last month), and 3.12% (last quarter).
Sales Growth
Beyond Meat’s sales growth is negative 22.4% for the current quarter and 12.2% for the next.
Yearly Top and Bottom Value
Beyond Meat’s stock is valued at $10.86 at 08:34 EST, way under its 52-week high of $44.59 and way above its 52-week low of $9.81.
More news about Beyond Meat.
9. Nio (NIO) – Premarket: 0.93%
NIO Inc. designs, develops, manufactures, and sells smart electric vehicles in China. It offers five and six-seater electric SUVs, as well as smart electric sedans. The company also offers power solutions, including Power Home, a home charging solution; Power Swap, a battery swapping service; Power Charger and Destination Charger; Power Mobile, a mobile charging service through charging vans; Power Map, an application that provides access to a network of public chargers and their real-time information; and One Click for Power valet service. In addition, it provides repair, maintenance, and bodywork services through its NIO service centers and authorized third-party service centers; statutory and third-party liability insurance, and vehicle damage insurance through third-party insurers; repair and routine maintenance; courtesy vehicle services; roadside assistance; data packages; and auto financing and financial leasing services. Further, the company involved in the provision of energy and service packages to its users; design and technology development activities; manufacture of e-powertrains, battery packs, and components; and sales and after sales management activities. Additionally, it offers NIO Certified, a used vehicle inspection, evaluation, acquisition, and sales service. The company was formerly known as NextEV Inc. and changed its name to NIO Inc. in July 2017. NIO Inc. was incorporated in 2014 and is headquartered in Shanghai, China.
NYSE ended the session with Nio dropping 4.82% to $7.54 on Friday, after three consecutive sessions in a row of losses. NYSE fell 0.31% to $14,975.97, after five sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Nio has a trailing twelve months EPS of $-1.38.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.79%.
Volatility
Nio’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.67%, a positive 0.03%, and a positive 3.48%.
Nio’s highest amplitude of average volatility was 6.62% (last week), 3.08% (last month), and 3.48% (last quarter).
Previous days news about Nio
- : nio, Tesla stocks fall in wake of disappointing Xpeng results. According to MarketWatch on Wednesday, 24 May, "Shares of Nio Inc. slumped 1.9% in premarket trading Wednesday, weighed down by rival China-based electric vehicle maker XPeng Inc. reported fell 1.2%, as the EV giant generated 21% of its first-quarter revenue from China. "
More news about Nio.
10. Pacific Biosciences of California (PACB) – Premarket: 0.84%
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
NASDAQ ended the session with Pacific Biosciences of California rising 0.25% to $11.97 on Friday while NASDAQ jumped 1.71% to $12,698.09.
Earnings Per Share
As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.27.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.97%.
Yearly Top and Bottom Value
Pacific Biosciences of California’s stock is valued at $11.97 at 08:34 EST, way under its 52-week high of $14.20 and way higher than its 52-week low of $3.85.
Volume
Today’s last reported volume for Pacific Biosciences of California is 3200860 which is 13.67% below its average volume of 3707840.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Pacific Biosciences of California’s stock is considered to be overbought (>=80).
More news about Pacific Biosciences of California.
Premarket Losers Today
1. Tilray (TLRY) – Premarket: -22.03%
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
NASDAQ ended the session with Tilray falling 2.69% to $2.36 on Friday, after three successive sessions in a row of losses. NASDAQ jumped 1.71% to $12,698.09, following the last session’s upward trend on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, Tilray has a trailing twelve months EPS of $-2.97.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.15%.
Previous days news about Tilray
- : tilray stock drops following announced secondary offering. According to MarketWatch on Thursday, 25 May, "At the close, Tilray shares were down 12.2% year to date, compared with an 8.1% gain on the S&P 500 index ."
More news about Tilray.
2. Canaan (CAN) – Premarket: -6.95%
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.
NASDAQ ended the session with Canaan jumping 0.19% to $2.58 on Friday while NASDAQ rose 1.71% to $12,698.09.
Earnings Per Share
As for profitability, Canaan has a trailing twelve months EPS of $0.4.
PE Ratio
Canaan has a trailing twelve months price to earnings ratio of 6.44. Meaning, the purchaser of the share is investing $6.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.64%.
More news about Canaan.
3. Nautilus (NLS) – Premarket: -3.2%
Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer and commercial use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates in two segments, Direct and Retail. It offers specialized cardio products, treadmills, ellipticals, bike products, home gyms, dumbbells, barbells, and kettlebells primarily under the Nautilus, Bowflex, Octane Fitness, and Schwinn brands, as well as fitness digital platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.
NYSE ended the session with Nautilus sliding 3.85% to $1.25 on Friday while NYSE fell 0.31% to $14,975.97.
Earnings Per Share
As for profitability, Nautilus has a trailing twelve months EPS of $-3.74.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -79.46%.
Sales Growth
Nautilus’s sales growth is negative 52.3% for the ongoing quarter and negative 13.2% for the next.
Moving Average
Nautilus’s value is below its 50-day moving average of $1.31 and way under its 200-day moving average of $1.66.
Volume
Today’s last reported volume for Nautilus is 199720 which is 11.82% above its average volume of 178603.
Revenue Growth
Year-on-year quarterly revenue growth declined by 33.4%, now sitting on 338.08M for the twelve trailing months.
More news about Nautilus.
4. Fox Corporation (FOX) – Premarket: -2.11%
Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional and virtual multi-channel video programming distributors (MVPDs) and other digital platforms, primarily in the U.S. It operates FOX News, a national cable news channel; FOX Business, a business news national cable channel; FS1 and FS2 multi-sport national networks; FOX Sports Racing, a video programming service that comprises motor sports programming; FOX Soccer Plus, a video programming network for live soccer and rugby competitions; FOX Deportes, a Spanish-language sports programming service; and Big Ten Network, a national video programming service. The Television segment acquires, produces, markets, and distributes programming. It operates The FOX Network, a national television broadcast network that broadcasts sports programming and entertainment; Tubi, an advertising-supported video-on-demand service; Fox Alternative Entertainment, a full-service production studio that develops and produces unscripted and alternative programming; MyNetworkTV, a programming distribution service; and Blockchain Creative Labs, which is focuses on the creation, distribution and monetization of Web3 content. This segment owns and operates 29 broadcast television stations. The Other, Corporate and Eliminations segment owns the FOX Studios Lot that provides production and post-production services, including 15 sound stages, two broadcast studios, theaters and screening rooms, editing rooms, and other television and film production facilities in Los Angeles, California. The company was incorporated in 2018 and is based in New York, New York.
NASDAQ ended the session with Fox Corporation jumping 0.94% to $28.92 on Friday, following the last session’s upward trend. NASDAQ rose 1.71% to $12,698.09, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.
Earnings Per Share
As for profitability, Fox Corporation has a trailing twelve months EPS of $2.14.
PE Ratio
Fox Corporation has a trailing twelve months price to earnings ratio of 13.51. Meaning, the purchaser of the share is investing $13.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.91%.
Yearly Top and Bottom Value
Fox Corporation’s stock is valued at $28.92 at 08:34 EST, way under its 52-week high of $34.42 and above its 52-week low of $26.35.
Volume
Today’s last reported volume for Fox Corporation is 3483560 which is 212.35% above its average volume of 1115270.
Moving Average
Fox Corporation’s value is under its 50-day moving average of $30.18 and under its 200-day moving average of $30.28.
Sales Growth
Fox Corporation’s sales growth is 5.7% for the ongoing quarter and 5.5% for the next.
More news about Fox Corporation.
5. Vodafone (VOD) – Premarket: -1.82%
Vodafone Group Public Limited Company engages in telecommunication services in Europe and internationally. The company offers mobile services that enable customers to call, text, and access data; fixed line services, including broadband, television (TV) offerings, and voice; and convergence services under the GigaKombi and Vodafone One names to customers. It also provides value added services, such as Internet of Things (IoT) comprising logistics and fleet management, smart metering, insurance, cloud, and security services; and automotive and health solutions. In addition, the company offers M-Pesa, an African payment platform, which provides money transfer, financial, and business and merchant payment services; and various services to operators through its partner market agreements. Vodafone Group Public Limited Company has a strategic partnership with Open Fiber. The company was incorporated in 1984 and is based in Newbury, the United Kingdom.
NASDAQ ended the session with Vodafone sliding 2.99% to $9.90 on Friday, after two successive sessions in a row of losses. NASDAQ rose 1.71% to $12,698.09, following the last session’s upward trend on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, Vodafone has a trailing twelve months EPS of $4.61.
PE Ratio
Vodafone has a trailing twelve months price to earnings ratio of 2.15. Meaning, the purchaser of the share is investing $2.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.47%.
Yearly Top and Bottom Value
Vodafone’s stock is valued at $9.90 at 08:34 EST, under its 52-week low of $9.94.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 22, 2022, the estimated forward annual dividend rate is 0.98 and the estimated forward annual dividend yield is 8.67%.
More news about Vodafone.
6. Virgin Galactic (SPCE) – Premarket: -1.48%
Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico.
NYSE ended the session with Virgin Galactic dropping 8.16% to $4.05 on Friday, after four successive sessions in a row of losses. NYSE fell 0.31% to $14,975.97, after five sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Virgin Galactic has a trailing twelve months EPS of $-2.37.
Volatility
Virgin Galactic’s last week, last month’s, and last quarter’s current intraday variation average was 0.41%, 1.53%, and 4.34%.
Virgin Galactic’s highest amplitude of average volatility was 8.27% (last week), 4.12% (last month), and 4.34% (last quarter).
Volume
Today’s last reported volume for Virgin Galactic is 19667000 which is 111.7% above its average volume of 9289940.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 20.9% and positive 12.7% for the next.
Sales Growth
Virgin Galactic’s sales growth is 625.5% for the present quarter and 368.1% for the next.
More news about Virgin Galactic.
7. Lloyds Banking Group (LYG) – Premarket: -0.89%
Lloyds Banking Group plc, together with its subsidiaries, provides a range of banking and financial services in the United Kingdom. It operates through three segments: Retail; Commercial Banking; and Insurance, Pensions, and Investments. The Retail segment offers a range of financial service products, including current accounts, savings, mortgages, motor finance, unsecured loans, leasing solutions, and credit cards to personal and small business customers. The Commercial Banking segment provides lending, transactional banking, working capital management, risk management, and debt financing services to small and medium-sized entities, corporates, and institutions. The Insurance, Pensions, and Investments segment offers insurance, investment, and pension management products and services. It also provides digital banking services. The company offers its products and services under the Lloyds Bank, Halifax, Bank of Scotland, and Scottish Widows brands. Lloyds Banking Group plc was founded in 1695 and is based in London, the United Kingdom.
NYSE ended the session with Lloyds Banking Group dropping 1.96% to $2.24 on Friday while NYSE dropped 0.31% to $14,975.97.
Earnings Per Share
As for profitability, Lloyds Banking Group has a trailing twelve months EPS of $0.39.
PE Ratio
Lloyds Banking Group has a trailing twelve months price to earnings ratio of 5.73. Meaning, the purchaser of the share is investing $5.73 for every dollar of annual earnings.
More news about Lloyds Banking Group.
8. Quidel (QDEL) – Premarket: -0.61%
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.
NASDAQ ended the session with Quidel dropping 2.52% to $84.72 on Friday while NASDAQ rose 1.71% to $12,698.09.
Earnings Per Share
As for profitability, Quidel has a trailing twelve months EPS of $-1.05.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.17%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 15.6%, now sitting on 3.11B for the twelve trailing months.
Sales Growth
Quidel’s sales growth is 0.6% for the current quarter and negative 7.6% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 86.8% and a negative 62.2%, respectively.
Volume
Today’s last reported volume for Quidel is 331676 which is 10.56% below its average volume of 370875.
More news about Quidel.
9. ING Group (ING) – Premarket: -0.55%
ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts. It also offers business lending products; consumer lending products, such as residential mortgage loans, term loans, and other consumer lending loans; and secured and unsecured lending services. in addition, the company provides debt capital market, working capital solutions, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, debt and equity market solutions, payments and cash management, and trade and treasury services, as well as savings, investment, insurance, mortgage, and digital banking services; and SME loans. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.
NYSE ended the session with ING Group falling 0.07% to $12.82 on Friday, after three sequential sessions in a row of losses. NYSE slid 0.31% to $14,975.97, after five consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, ING Group has a trailing twelve months EPS of $1.44.
PE Ratio
ING Group has a trailing twelve months price to earnings ratio of 8.9. Meaning, the purchaser of the share is investing $8.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.17%.
More news about ING Group.
10. Catalyst Pharmaceuticals (CPRX) – Premarket: -0.52%
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
NASDAQ ended the session with Catalyst Pharmaceuticals sliding 1.36% to $11.59 on Friday while NASDAQ jumped 1.71% to $12,698.09.
Earnings Per Share
As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.88.
PE Ratio
Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 13.17. Meaning, the purchaser of the share is investing $13.17 for every dollar of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Catalyst Pharmaceuticals’s stock is considered to be overbought (>=80).
More news about Catalyst Pharmaceuticals.
Stay up to date with our premarket winners and losers daily report
